Objective: We investigated the risk factors for metastasis to retropharyngeal lymph nodes (RPLNs) and the significance of dissection of RPLNs in hypopharyngeal cancer. Metastasis to the RPLNs is an important prognostic factor in head and neck cancer, especially in hypopharyngeal cancer. Methods: Study subjects were 129 cases who received primary treatment at nine leading medical facilities in the field of head and neck cancer management in Japan. Focusing on RPLNs, we compared prognosis in RPLN-metastasis-positive, RPLN-metastasis-negative, RPLN-dissected and RPLN-non-dissected cases.
INTRODUCTION
Among head and neck cancers, hypopharyngeal cancer is most often detected at an advanced stage and has a poor prognosis, with a 5-year survival rate of 31 -47% (1 -4) . One reason is that the abundant lymph flow from the hypopharynx allows early metastasis to cervical lymph nodes. Approximately 70% of patients already have cervical node metastasis at the initial examination (1, 5) . Metastasis to retropharyngeal lymph nodes (RPLNs) is recognized as an important prognostic factor in hypopharyngeal cancer (6) (7) (8) (9) (10) .
RPLNs exist in the parapharyngeal space and are classified as either medial or lateral RPLNs. The latter were first described by Rouvière (11) as nodes that poured lymph from the epipharynx, mesopharynx, hypopharynx, nasal cavity, ethmoidal sinus and sphenoidal sinus into the lymph flow of the internal jugular vein. These lymph nodes, known as Rouvière lymph nodes, represent 'retropharyngeal nodes' when sites of metastasis are discussed. In contrast, medial RPLNs are rarely involved in metastasis, partly because of their small size (6) .
In 1964, Ballantyne (6) first noticed RPLNs as a site of metastasis of head and neck cancer, stating that 'the lymphatic structures which lie between the carotid arteries have received comparatively little attention as the site of metastasis'. In the 40 years since their report, little literature has become available on metastasis to RPLNs of head and neck cancer except for studies on head and neck cancer as a whole (7, 8) , mesopharyngeal/hypopharyngeal cancer (9) and hypopharyngeal/cervical esophageal cancer (10) . Hypopharyngeal cancer metastasizes very frequently to RPLNs (8,9) compared with head and neck cancer at other sites; nevertheless, there has been no study limited to hypopharyngeal cancer. In addition, criteria of RPLN dissection for hypopharyngeal cancer vary between each institution in Japan and it is desirable to standardize the criteria according to stage.
Thus, we investigated the results of treatment for hypopharyngeal cancer in Japan, the correlation between RPLN dissection and RPLN metastasis, and risk factors for RPLN metastasis in order to discuss the significance of RPLN dissection in the treatment of hypopharyngeal cancer.
PATIENTS AND METHODS

PATIENT POPULATION
Studied were 129 cases of hypopharyngeal cancer whose primary treatment was initiated from August 1999 to November 2000 at the nine facilities shown in Table 1 and were followed until July 2006 or until the time of death. There were 117 males (90.7%) and 12 females (9.3%), with a mean age at the initial examination of 63.1 years (42 -87 years). The average follow-up period was 42.5 months (range 2 -86 months). These cases were classified according to the 1977 UICC classification system and staged by the TNM system or by subsite. Because this investigation was a multicenter study, initial treatment modalities for the primary hypopharyngeal cancer as well as cervical metastatic nodes varied from one facility to another.
TOTAL SURVIVAL
We calculated the crude and disease-specific 5-year survival rates for the study group, as well as the crude 5-year survival rates according to disease stage.
LATERAL RPLN METASTASIS
The diagnosis of RPLN metastasis was made from surgical pathologic findings or radiographic findings at the initial treatment or during follow-up. We examined the correlation between the incidence of RPLN metastasis during the follow-up period and stages of the TNM classification. Furthermore, to determine whether the prognosis was influenced by the presence of RPLN metastasis, we compared the survival rates of patients who did and did not undergo RPLN dissection at the time of primary treatment. We also compared the incidence of RPLN metastases among different stages at each subsite.
STATISTICAL ANALYSIS
Survival rates were calculated using the Kaplan -Meier method and their differences were examined by the log-rank test in every case. Correlations between the incidence of RPLN metastasis and stage of the TNM classification were examined by the Mann -Whitney U-test. The incidence of RPLN metastases in different subsites was examined for significance by the Fisher exact probability test. The significant level was defined as P , 0.05 in every test. Tables 2 and 3 show disease stages in the total patient population and for hypopharyngeal cancer according to subsite. The disease was advanced at the time of diagnosis in the majority of cases, with 67% having Stage IV disease, whereas 5% had Stage I, 9% Stage II and 19% Stage III. That cervical lymph node metastasis occurred early was suggested by the result that Stage IV (N classification) cases comprised 60% of patients, whereas Stage IV (T classification) comprised 24% of patients. The incidence of metastasis according to subsite was 78% for the piriform sinus, 12% for the post-cricoid area (PC) and 10% for the posterior wall (PW).
RESULTS
DISEASE STAGES
TREATMENT
Details of primary treatment of the lesions and management of cervical lymph nodes are shown in Table 4 . Both the primary cancer and metastatic cervical lymph nodes were most often treated only by surgery, with the combination of surgery and post-operative radiation therapy being the second most frequently employed treatment. Because this Table 1 . Participating institutions was a multicenter study, the criteria for radiation to RPLNs were inconsistent among institutions. In some institutions, all cases regardless of the presence of metastasis received radiation therapy, but in others, only cases with positive nodes were given radiation therapy.
FIVE-YEAR SURVIVAL RATES
The crude 5-year survival rate for the whole series was 41.1%, whereas that of disease-specific survival was 52.2% ( Fig. 1) . The crude stage-specific 5-year survival rates were 83.3% (n ¼ 6) for Stage I, 50.0% (n ¼ 12) for Stage II, 50.0% (n ¼ 24) for Stage III and 34.5% (n ¼ 87) for Stage IV (Fig. 2) .
RPLN METASTASIS AND PROGNOSIS
Of the entire series, 17 (13.2%) incurred RPLN metastasis during the follow-up period. The crude 5-year survival rates depended on the state of RPLN metastasis: 44.6% (n ¼ 112) for the RPLN-metastasis-negative group and 17.6% (n ¼ 17) for the RPLN-metastasis-positive group, with a significantly higher survival rate in the RPLN-metastasis-negative group ( Fig. 3 , P ¼ 0.017, log-rank test).
COMPARISON OF PROGNOSIS IN RELATION TO RPLN METASTASES IN PATIENTS WHO UNDERWENT RPLN DISSECTION
Thirty-two cases underwent RPLN dissection at the time of primary treatment and 97 did not. Of those 32 patients, 30.0% (n ¼ 10) in the RPLN-metastasis-positive group survived for 5 years, whereas 41.2% (n ¼ 22) of the RPLN-metastasis-negative group survived for 5 years. There was no statistically significant difference between these survival rates (Fig. 4) . Among the 17 cases having RPLN metastasis, 30.0% in the RPLN-dissected group (n ¼ 10) survived for 5 years versus none of those in the RPLN-non-dissected group (n ¼ 7). In the RPLN-dissected group, one case was Stage II, one was Stage III, seven were Stage IVa and one was Stage IVb. In the non-dissected group, five cases were Stage IVa and two were Stage IVb. All of the 10 cases who underwent RPLN dissection as the initial treatment were metastasis positive, but there was no 
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Retropharyngeal lymph node metastasis RPLN recurrence among these patients. On the other hand, among RPLN-non-dissected group (n ¼ 7), one case was diagnosed as having RPLN metastasis at the initial treatment, but in the other six cases, RPLN metastasis was diagnosed subsequently.
RISK FACTORS FOR RPLN METASTASIS
In the 17 cases who had RPLN metastasis during the therapeutic course, RPLN metastasis had no clear correlation with levels of progression as defined by the T or N classification (Table 5 , P ¼ 0.938 for the T classification and P ¼ 0.295 for the N classification: Mann -Whitney's U-test).
When the incidence of RPLN metastasis by subsite was analyzed in these 17 cases, results showed a statistically significantly higher incidence in patients whose primary cancer occurred at the PW or the PC compared with that at the piriform sinus (Table 6 , P ¼ 0.020 , 0.05: Fisher's exact probability test).
DISCUSSION
Although recent developments in molecular oncology have disclosed the presence of molecular markers that could predict the prognosis of hypopharyngeal cancer (12), traditional clinical features remain the basis for prediction of tumor behavior and choice of therapeutic options. Prognostic factors related to controlling lymph node metastases in head and neck cancer were reported to include N stage, node size and location of lymph node metastasis (2); macroscopic extranodal extension of node metastasis in hypopharyngeal cancer (13); pre-operative lymph node biopsy or histopathologic findings of invasion of blood/ lymph vessels (14) ; and the well-known importance of RPLN metastasis. However, correlation of RPLN metastasis with prognosis has been rarely studied. Since 1964 when Ballantyne for the first time recognized RPLNs as metastatic sites of head and neck cancer, data have been limited to studies of head and neck cancer as a whole (7, 8) , mesopharyngeal and hypopharyngeal cancer (9) , and cancer of the hypopharynx and cervical esophagus (10) . The small number of studies may be explained by difficulty in conducting a large-scale retrospective investigation of RPLN metastasis, which was not included in the N system of the UICC classification, the global standard of cancer staging.
McLaughlin et al. (7) studied RPLN metastases from images taken in 605 cases of non-nasopharyngeal squamous cell carcinoma of the head and neck and stressed the importance of RPLNs as a prognostic factor in head and neck cancer. Among their cases, RPLN metastasis was detected in 42 (6.2%), and both the incidence of recurrent neck cancer and distant metastasis were statistically significantly higher in the RPLN-metastasis-positive group than in the RPLN-metastasis-negative group, whereas the survival rate was lower. In our present study, 13% of patients in our series comprising 129 patients had RPLN metastasis, indicating a tendency toward a higher incidence of metastasis in our patients than in those with head and neck cancer as a whole as reported by McLaughlin et al. The presence of RPLN metastasis significantly influenced the crude 5-year survival rate, thus should be appreciated as an important prognostic factor, especially in hypopharyngeal cancer.
Gross et al. (8) studied relationships between RPLN dissection and prognosis in 51 cases of advanced nonnasopharyngeal squamous cell carcinoma of the head and neck and found no difference in local recurrence, distant metastasis or survival rates between the histopathologically proven RPLN-metastasis-positive and RPLN-metastasisnegative groups. Hasegawa and Matsuura (9) performed RPLN dissection in 24 cases of advanced mesopharyngeal or hypopharyngeal cancer and found histopathologic metastases in the lymph node specimens in 50% of these cases but found no significant difference in the survival rate between metastasis-positive and metastasis-negative patients. In a study of 182 cases of hypopharyngeal cancer or cancer of the cervical esophagus, Amatsu et al. (10) reported that the rate of death from RPLN metastasis was significantly lower in the RPLN-dissected group, although there was no significant difference in the overall survival rate between the RPLN-dissected and RPLN-non-dissected groups.
Also, in the present study, the survival rate in the RPLN-dissected group was not significantly influenced by the presence of node metastasis. As shown in the Results section, all 10 cases with the diagnosis of RPLN metastasis at the initial treatment who underwent RPLN dissection did not experience recurrence. However, in those who did not undergo RPLN dissection (n ¼ 7), six were diagnosed subsequently with RPLN metastasis and one had RPLN metastasis at the initial treatment; this metastatic disease was uncontrollable. Statistical comparisons of prognosis were difficult between RPLN-dissected and RPLN-non-dissected groups as treatment modalities differed according to the institution, but that the 5-year survival rate of patients with RPLN metastasis in the RPLN-non-dissected group was null indicated a tendency for a better prognosis in the RPLNdissected cases.
Gross et al., in discussing the finding that the prognosis in an RPLN-dissected group was not significantly influenced by the presence of node metastasis, stated that these results seemed to defy clinical logic and early dogma. However, it might be accepted that RPLN dissection could secure a comparable prognosis irrespective of RPLN metastasis, judging from results of the present study showing that secondary metastasis is difficult to control and that patients in the RPLN-dissected group having metastasis tended to have a better prognosis than the RPLN-non-dissected group. Hence, RPLN dissection should be recommended for the treatment of hypopharyngeal cancer.
What is the reason for the equivalent prognosis that was achieved with RPLN dissection irrespective of the presence or absence of RPLN metastasis? Why does RPLN metastasis occur more frequently in hypopharyngeal cancer than in cancer of other sites of the head and neck? A study of the lymphatic pathway of the mesopharynx and hypopharynx using cadavers disclosed that the lymphatic pathway of the mesopharynx flows mostly into the lateral pharyngeal nodes and rarely into RPLNs, whereas the lymphatic pathway of the hypopharynx involves lymph vessels running into RPLNs in an ascending direction and despite the relatively long distance to go that was noted in many of the cadavers examined (15) . Results of that investigation offer the reason why RPLN metastasis is not infrequent in hypopharyngeal cancer.
Rouvière (11) pointed out that RPLNs were first echelon nodes, like the internal jugular chain, so it was considered possible that RPLN dissection at the time of primary treatment controlled the effects of RPLN metastasis on prognosis. In the present study, RPLN metastasis was not correlated with the N classification stage, and studies of Amatsu et al. (10) and Hasegawa and Matsuura (9) showed that not a small number of pN0 cases had RPLN metastases. This can be explained by the anatomic feature that RPLNs are the first echelon nodes in the ascending pathway.
In the present examination of primary subsites, it was shown that patients with primary PC (25%) and PW cancer (31%) more frequently incurred RPLN metastasis than those with piriform sinus cancer (9.0%) (P ¼ 0.020). Previous papers reported a higher incidence of RPLN metastasis especially in PW cancer (57 -67%) compared with piriform sinus cancer (17 -50%) (9, 10) , suggesting that the abovementioned ascending pathway is more involved in PW cancer in the light of the anatomic location. Accordingly, RPLN dissection is more strongly recommended in PW and PC cancer than in piriform sinus cancer. The UICC classification does not include evaluation of RPLN metastasis (16) , which is considered important in formulating a therapeutic strategy and for prediction of the prognosis in hypopharyngeal cancer on the basis of the above-mentioned clinical and anatomical data. Therefore, we recommend that RPLNs should be included as regional lymph nodes for hypopharyngeal cancer in the classification of lymph nodes and that the presence of RPLN metastasis should be evaluated as a standard algorithm in patients with hypopharyngeal cancer.
CONCLUSION
We studied the relationships between RPLN metastasis and prognosis in 129 hypopharyngeal cancer cases. We recommend RPLN dissection in the primary treatment of hypopharyngeal cancer, especially in PC/PW cancer for the following reasons: i) RPLN dissection is expected to improve prognosis, since RPLNs are the first echelon nodes of the hypopharynx from an anatomic point of view. ii) Primary cancer of the PC/PW subsites is a risk factor for RPLN metastasis.
